Calcium Folinate: clinical trials recruiting now
4
Recruiting trials
4
Conditions studied
0
US states with sites
2
Countries
FDA drug label
- FDA-approved
- Yes. Calcium Folinate appears in the FDA drug-label database. Marketed as LEDERLE LEUCOVORIN.
FDA recalls / enforcement
| Reason (FDA) | Classification | Status | Initiated |
|---|---|---|---|
| Failed Tablet/Capsule Specifications: Tablets are imprinted with the incorrect identification code. — West-Ward Columbus Inc | Class III (FDA: unlikely to cause harm) | Terminated | 2020-07-22 |
Phase breakdown
Phase 1 1
Phase 2 3
Conditions being studied
| Condition | Trials |
|---|---|
| Colorectal cancer | 2 |
| Metastatic Colorectal Cancer | 2 |
| Pancreatic Cancer | 2 |
| Pancreatic Cancer Metastatic to Liver | 1 |
Recruiting trials involving Calcium Folinate
- A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI
- A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
- Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety
- Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer
Common questions
Is Calcium Folinate FDA-approved?
Yes, marketed as LEDERLE LEUCOVORIN.
How many recruiting trials involve Calcium Folinate?
4 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.